By blocking TSP1 from binding to its cell surface receptor (CD47) normal tissue becomes nearly immune to cancer radiation therapy and assists in tumor death.
Bloquear a unión de TSP1 ao seu receptor da superficie celular (CD47) fai que o tecido normal se volva case inmune á terapia de radiación contra o cancro e axuda á morte do tumor.